{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:54:06Z","timestamp":1777910046702,"version":"3.51.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"\n Purpose:<\/jats:title>\n \n Renin\u2013angiotensin system (RAS) is expressed in neuronal tissue and plays a role in neurodegenerative diseases involving excitotoxicity as a pathophysiological mechanism. In retina, excessive excitatory neurotransmission via\n N<\/jats:italic>\n -methyl-\n d<\/jats:sc>\n -aspartate (NMDA) receptors underlies neuronal apoptosis in conditions like glaucoma. However, it is not known if NMDA-mediated excitotoxicity alters retinal RAS expression. Hence, this study investigated the effect of NMDA exposure on the expression of RAS in rat retinas.\n <\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Two groups of Sprague\u2013Dawley rats received either phosphate buffer saline or NMDA (160 nmol). On day 7 posttreatment, retinal expression of RAS components including renin, angiotensinogen, angiotensin-converting enzyme (ACE), angiotensin II (Ang II), Ang 1\u20137, Ang 1\u20139, MAS receptor, angiotensin II type 1 receptor (AT1R), ACE2, and aldosterone was measured using enzyme-linked immunosorbent assay and polymerase chain reaction. Morphometric studies were done to assess morphological alterations.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Following the exposure to NMDA, an upregulation of ACE expression was noted at both the protein (2.03-folds;\n P<\/jats:italic>\n < 0.001) and mRNA (1.86-folds;\n P<\/jats:italic>\n < 0.01) levels in rat retinas. AT1R protein and mRNA expression were greater by 1.73 (\n P<\/jats:italic>\n < 0.0001) and 2.28-folds (\n P<\/jats:italic>\n < 0.0001), respectively. However, mRNA expression for ACE2, Ang 1\u20137, and Ang 1\u20139, showed a 1.51-(\n P<\/jats:italic>\n < 0.05), 2.41-(\n P<\/jats:italic>\n < 0.001), and 2.37-(\n P<\/jats:italic>\n < 0.0001) fold decrease. Ganglion cell layer (GCL) thickness and linear cell density in GCL were significantly lower in the NMDA-treated group (\n P<\/jats:italic>\n < 0.05).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n NMDA exposure increases expression of the classical RAS and suppresses that of alternate RAS in rat retinas. These alterations are associated with retinal morphological changes indicating significant loss of neuronal cells in the GCL of rat retinas.<\/jats:p>\n <\/jats:sec>","DOI":"10.1089\/jop.2024.0131","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:22:22Z","timestamp":1733998942000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["N<\/i>\n -Methyl-\n d<\/scp>\n -Aspartate-Induced Excitotoxicity and Its Impact on the Renin\u2013Angiotensin System in Retinal Tissue"],"prefix":"10.1177","volume":"41","author":[{"given":"Abdul Malick Sahib","family":"Mohammed Irfan","sequence":"first","affiliation":[{"name":"School of Medicine, Human biology department, IMU University, Kuala Lumpur, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Geoffrey","sequence":"additional","affiliation":[{"name":"School of Medicine, IMU University, Kuala Lumpur, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Htet","family":"Htet","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Pathology and Pharmacology, IMU University, Kuala Lumpur, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purushotham","family":"Krishnappa","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Pathology and Pharmacology, IMU University, Kuala Lumpur, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norhafiza","family":"Razali","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Teknologi Mara, Selangor, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Iezhitsa","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Pathology and Pharmacology, IMU University, Kuala Lumpur, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Agarwal","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Pathology and Pharmacology, IMU University, Kuala Lumpur, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"e_1_3_4_2_2","first-page":"495","article-title":"Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress","volume":"24","author":"Jafri AJA","year":"2018","unstructured":"Jafri AJA, , Agarwal R, , Iezhitsa I, et al. Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress. Mol Vis. 2018; 24:495\u2013508. http:\/\/www.molvis.org\/molvis\/v24\/495\/","journal-title":"Mol Vis"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2009.24"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/528940"},{"issue":"7","key":"e_1_3_4_5_2","first-page":"1450","article-title":"Renin-containing M\u00fcller cells of the retina display endocrine features","volume":"36","author":"Berka JL","year":"1995","unstructured":"Berka JL, , Stubbs AJ, , Wang DZ, et al. Renin-containing M\u00fcller cells of the retina display endocrine features. Invest Ophthalmol Vis Sci, 1995; 36(7):1450\u20131458.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-1-160"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107770"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2016.09.009"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/1470320314549791"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2020.1758341"},{"key":"e_1_3_4_11_2","first-page":"1443","article-title":"Expression and cellular localization of the Mas receptor in the adult and developing mouse retina","volume":"20","author":"Prasad T","year":"2014","unstructured":"Prasad T, , Verma A, , Li Q. Expression and cellular localization of the Mas receptor in the adult and developing mouse retina. Mol Vis, 2014; 20:1443\u20131455.","journal-title":"Mol Vis"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2014.03.011"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040610"},{"issue":"5","key":"e_1_3_4_14_2","first-page":"746","article-title":"Dose-dependent effects of NMDA on retinal and optic nerve morphology in rats","volume":"12","author":"Lambuk L","year":"2019","unstructured":"Lambuk L, , Jafri AJA, , Iezhitsa I, et al. Dose-dependent effects of NMDA on retinal and optic nerve morphology in rats. Int J Ophthalmol. 2019; 12(5):746\u2013753.","journal-title":"Int J Ophthalmol"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.310691"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2016.09.005"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.2.159"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00002.2008"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-1024"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2017.32"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2012.04.008"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-21001"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbrainres.2004.06.001"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0447-18.2018"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.11.022"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-01800-9"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.296"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00090"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2000.0866"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141137"},{"issue":"2","key":"e_1_3_4_31_2","first-page":"238","article-title":"Topical losartan reduces IOP by altering tm morphology in rats with steroid-induced ocular hypertension","volume":"62","author":"Agarwal R","year":"2018","unstructured":"Agarwal R, , Krasilnikova A, , Mohamed SNL, et al. Topical losartan reduces IOP by altering tm morphology in rats with steroid-induced ocular hypertension. Indian J Physiol Pharmacol. 2018; 62(2):238\u2013248.","journal-title":"Indian J Physiol Pharmacol"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-199906000-00012"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(00)00138-x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(01)00964-3"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.53049"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma202113703186"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology9030045"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2024.0131","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2024.0131","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2024.0131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:46:42Z","timestamp":1777646802000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2024.0131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,1]]}},"alternative-id":["10.1089\/jop.2024.0131"],"URL":"https:\/\/doi.org\/10.1089\/jop.2024.0131","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}